A CDSCO nephrology medical device license is mandatory under India's Medical Devices Rules, 2017 for any manufacturer or importer of notified nephrology devices — including haemodialysis machines, dialysers, peritoneal dialysis systems, and kidney stone retrieval devices. Nephrology devices span Class A through Class D. Manufacturing Class A and B devices requires a Form MD5 license from the State Licensing Authority (fee: Rs. 5,000 plus Rs. 500 per device). Manufacturing Class C and D devices requires a Form MD9 license from CDSCO Central (fee: Rs. 50,000 plus Rs. 1,000 per device). Importing any class requires a Form MD15 import license from CDSCO. All three license types are valid indefinitely, subject to a retention fee paid every 5 years — non-payment results in automatic cancellation. Applications are submitted through the CDSCO SUGAM portal (cdscoonline.gov.in). ISO 13485 certification and a Device Master File are mandatory for all manufacturing license applications.
Nephrology is the medical discipline concerned with kidney health — the prevention, diagnosis, and treatment of kidney disease. Most kidney conditions arise from the kidneys' diminishing ability to properly filter waste products from the blood, a decline that, left unmanaged, becomes life-threatening. Nephrology medical devices — from haemodialysis machines that perform this filtration mechanically to dialysers, peritoneal dialysis systems, and kidney stone retrieval devices — therefore carry a vital, often lifesaving role, while also being central to improving the day-to-day quality of life for patients living with chronic kidney disease.
India faces a significant and growing gap between the demand for specialised nephrology care and the supply of devices and services able to meet it. This gap has made nephrology one of the more closely regulated segments within CDSCO's medical device framework — the agency's objective being to ensure that as device manufacturers and importers move to meet this demand, only devices that meet rigorous quality and safety standards reach Indian patients. This guide explains what nephrology device manufacturers and importers need to know to secure CDSCO licensing in India.
📑 Quick Navigation
- Demand for Nephrology Medical Devices in India
- CDSCO Regulations for Nephrology Devices: Mandatory Compliance
- CDSCO Classification: Nephrology Devices by Class
- Mandatory Documents for CDSCO Nephrology Device License
- Three CDSCO License Types: MD5, MD9, MD15
- 5-Step Application Process Through CDSCO SUGAM
- License Validity and Retention Fee Requirements
- 5 Benefits of CDSCO Licensing for Nephrology Device Manufacturers
- How Rego Services Supports Your CDSCO Application
- Frequently Asked Questions
Demand for Nephrology Medical Devices in India
The demand for specialised nephrology medical devices in India remains substantially underserved relative to the scale of the underlying disease burden. Early diagnosis and treatment occur at comparatively low rates, in large part due to a shortage of accessible screening devices. Compounding this, secondary and tertiary prevention measures are implemented inconsistently, since most patients seek medical attention only once symptoms become apparent — by which point the underlying kidney condition has frequently progressed to an advanced stage.
Several converging factors are driving growth in India's nephrology medical device market. Rising rates of diabetes and hypertension — the two leading risk factors for chronic kidney disease — are directly increasing the population requiring nephrology intervention. At the same time, continuous innovation in haemodialysis technology is expanding what is clinically possible: modern haemodialysis machines now offer precise dialysis treatment with enhanced safety mechanisms, real-time monitoring capabilities, and improved user interfaces, driving replacement and upgrade demand among existing dialysis centres. Growing public awareness of the value of early diagnosis is increasing demand for screening and diagnostic nephrology devices, and government-led initiatives to expand early detection and screening infrastructure are reinforcing this trend at a policy level.
For medical device companies, this combination of underserved demand and structural growth drivers presents a genuine commercial opportunity — particularly for manufacturers and importers willing to focus on screening and diagnostic nephrology devices, which remain especially scarce relative to therapeutic devices like haemodialysis machines. Entrepreneurs and established device companies entering this segment of the Indian healthcare market are positioned to address a need that is both clinically urgent and commercially substantial.
CDSCO Regulations for Nephrology Devices: Mandatory Compliance
Venturing into India's nephrology medical device sector is a commercially attractive proposition, but medical device companies must approach it with full awareness of the applicable CDSCO regulatory requirements. Precisely because demand for nephrology devices is so high, the Indian market carries a heightened risk of substandard devices entering circulation — devices whose failure or underperformance can have a direct, detrimental impact on patient outcomes for an already vulnerable patient population.
CDSCO's regulatory priorities for this category are explicit: improved patient outcomes and safety, and effective healthcare delivery. Given the vital clinical role nephrology devices play and the scale of demand they serve, CDSCO has formulated stringent regulations specific to this device category under the Medical Devices Rules, 2017. Securing the applicable CDSCO nephrology medical device license is therefore not a discretionary compliance step — it is a mandatory legal requirement for any company seeking to manufacture or import these devices in India.
CDSCO Classification: Nephrology Devices by Class
The Medical Devices Rules, 2017 classify all notified medical devices into four risk-based classes — A (lowest risk) through D (highest risk) — to calibrate regulatory requirements to patient risk. Specific application processes and license types apply to specific CDSCO classes, so understanding where a nephrology device sits in this classification system is the essential first step before any license application begins. The following provides real device examples for each class within the nephrology category.
- Crimp for plier, Haemodialysis
- Chair, Haemodialysis — Electrically powered
- Chair, Haemodialysis — Manual
- Urinary stone retrieval basket
- Dialyser connector
- Laser lithotripsy fibre / suction guide
- Peritoneal dialysis catheter guidewire
- Peritoneal dialysis ultraviolet irradiation unit
- Shunt thrombus suction set
- Citric acid haemodialysis system cleaning cartridge
- Extracorporeal circuit waste bag
- Haemodialysis dialysate water chlorine test kit / strip
- Automated peritoneal dialysis system
- Dialysis apheresis unit, Therapeutic
- Haemodialyzer reprocessing system
- Haemofilters
- Hemodiafiltration system
- Hollow-fibre haemodialysis dialyser
- Kidney donor-organ preservation / transport system
- Kidney stone filter
- Multi-patient dialysis fluid delivery system
- Peritoneal dialysis catheter adaptor
- Sodium carbonate haemodialysis system cleaning cartridge
- Peritoneal dialysis system dialysate filter
- Haemodialysis system plasma filtration unit
- Haemodialysis system central monitor
- Haemodialysis system bicarbonate mixer
- Haemodialysis system air / foam detector
- Absorbable peritoneum catheter cuff
- Collagen-containing peritoneum absorbable catheter cuff
Mandatory Documents for CDSCO Nephrology Device License Application
To apply for a CDSCO nephrology medical device license, applicants must prepare a defined set of supporting documents. The completeness and quality of this document set is the single largest factor influencing how smoothly and quickly the application proceeds through CDSCO review.
- Organisation identity proof — Certificate of Incorporation, Memorandum and Articles of Association, GST registration certificate, and other applicable documents establishing the legal identity and standing of the applicant company.
- Sale Deed or Rent Deed of the premises — Valid documentary evidence of the applicant's right to occupy the declared manufacturing facility or registered premises.
- Building Layout with dimension — An accurate, dimensioned floor plan of the manufacturing facility showing production areas, quality control laboratory, storage zones, and personnel facilities, prepared in accordance with CDSCO requirements.
- Plant Master File (PMF) — A comprehensive document describing the manufacturing facility's location, layout, process flows, equipment, calibration and maintenance programme, and quality management infrastructure. For Class C and D nephrology devices — given their direct circulatory contact — the PMF must demonstrate rigorous GMP compliance.
- Device Master File (DMF) — A comprehensive technical dossier covering the nephrology device's design, intended use, manufacturing process, risk management file, biocompatibility and performance testing data, labelling and Instructions for Use, and post-market surveillance plan. For devices that interface directly with the patient's blood — dialysers, haemofilters, extracorporeal circuit components — biocompatibility and haemocompatibility data are a critical and closely scrutinised element of the DMF.
- Documents for the team of qualified staff — Curriculum vitae, qualifications, and appointment letters for personnel responsible for manufacturing and testing the nephrology devices, demonstrating that CDSCO's minimum qualification requirements are met.
- Environmental regulation compliance documents — Applicable Pollution Control Board clearances and waste disposal documentation, particularly relevant where manufacturing generates regulated chemical or biological waste streams.
- Certificate of Analysis of 3 consecutive batches — Documentary proof that the manufacturing process consistently produces nephrology devices meeting declared specifications. For first-time manufacturers, these batches must be produced under a valid CDSCO test license.
- ISO 13485 Certificate — A current, in-scope certificate from an IAF-accredited certification body, covering the manufacturing activities relevant to the nephrology device being licensed. This is a mandatory hard requirement for MD5 and MD9 applications.
- Test License, if required for testing the device — Where production batches were manufactured under an MD13 test license prior to the permanent license application, a copy of that test license must be included to contextualise the batch data submitted.
For Class C and D nephrology devices — haemofilters, dialysers, hemodiafiltration systems, and absorbable catheter cuffs — the biocompatibility and haemocompatibility data within the Device Master File receives particularly close CDSCO scrutiny, given the device's direct and sustained contact with the patient's bloodstream. Manufacturers should ensure this testing data is comprehensive, current, and clearly presented, since gaps here are one of the most common sources of reviewer queries for nephrology device applications.
CDSCO Medical Device Test License (MD13 / MD17) India 2026 — Complete Guide
If you are a first-time manufacturer of nephrology medical devices and need to produce the three consecutive batch Certificate of Analysis required for your MD5 or MD9 application, an MD13 test license is the legally required first step. This guide covers the complete test license process — mandatory documents, the 5-step SUGAM application, and validity rules.
Three CDSCO License Types: MD5, MD9, MD15
Three distinct CDSCO license types apply to nephrology medical devices, determined by whether the applicant is manufacturing or importing, and — for manufacturers — the risk class of the device.
Manufacturing Class A and B nephrology devices — such as haemodialysis chairs and crimp pliers — requires an MD5 license, with a manufacturing license fee of Rs. 5,000 plus Rs. 500 for each distinct device, obtained from the State Licensing Authority. Manufacturing Class C and D nephrology devices — such as haemofilters, automated peritoneal dialysis systems, and absorbable catheter cuffs — requires an MD9 license, with a fee of Rs. 50,000 plus Rs. 1,000 for each distinct device, obtained from the Central Licensing Authority. Importing nephrology devices of any class into India requires an MD15 import license secured from CDSCO.
5-Step Application Process Through CDSCO SUGAM
The CDSCO nephrology medical device license application follows a defined five-step process, filed entirely through the CDSCO SUGAM online portal at cdscoonline.gov.in.
Compile all necessary documents required for the license application — organisation identity proof, premises documents, building layout, Plant Master File, Device Master File, qualified personnel documentation, environmental compliance documents, Certificate of Analysis for three consecutive batches, ISO 13485 certificate, and test license (if applicable). All supporting documents must be meticulously prepared and internally reviewed for consistency before submission.
File the application online on CDSCO's official SUGAM portal at cdscoonline.gov.in, selecting the applicable license form — MD5, MD9, or MD15 — based on the confirmed device classification. Carefully attach all necessary supporting documents in the formats and sizes specified by the portal, and pay the applicable government fee to formally submit the application.
CDSCO may raise queries on the submitted application and documents, particularly relating to the Device Master File's risk management and biocompatibility data for higher-class nephrology devices. These queries have to be promptly and accurately addressed through the SUGAM portal — delayed or incomplete responses extend the application timeline significantly.
For manufacturing license applications (MD5 and MD9), regulatory officials may visit the medical device facility for inspection, to ensure regulatory compliance with the manufacturing processes, quality systems, and personnel qualifications declared in the Plant Master File and Device Master File.
Once all the criteria are satisfied — queries resolved and inspection findings (where applicable) cleared — CDSCO will grant the applicable nephrology medical device license: Form MD5, MD9, or MD15, issued through the SUGAM portal.
License Validity and Retention Fee Requirements
The CDSCO nephrology medical devices license is valid indefinitely from the date of grant. However, the license retention fee has to be paid every 5 years — failure to do so results in the license being cancelled automatically, requiring a fresh application to resume manufacturing or import activity.
| Parameter | MD5 — Class A/B Manufacture | MD9 — Class C/D Manufacture | MD15 — Import All Classes |
|---|---|---|---|
| Validity | Indefinite | Indefinite | Indefinite |
| Retention fee cycle | Every 5 years | Every 5 years | Every 5 years |
| Effect of non-payment | Automatic cancellation | Automatic cancellation | Automatic cancellation |
| Issuing authority | State Licensing Authority | CDSCO (Central) | CDSCO (Central) |
| Initial license fee | Rs. 5,000 + Rs. 500/device | Rs. 50,000 + Rs. 1,000/device | Class-dependent |
5 Benefits of CDSCO Licensing for Nephrology Device Manufacturers
A valid CDSCO license is the legal prerequisite for placing nephrology devices on the Indian market — a market characterised by rising chronic kidney disease incidence and a persistent shortfall in specialised device availability. Obtaining the license converts this underserved demand into a legally accessible commercial opportunity, while ensuring the manufacturer operates within the regulatory framework CDSCO has established specifically because of the elevated patient risk this device category carries.
Nephrologists, dialysis centre operators, and hospital procurement teams are acutely aware of the clinical stakes associated with devices that interface directly with a patient's bloodstream. CDSCO licensing — backed by ISO 13485 certification and comprehensive biocompatibility data — signals that a manufacturer's haemodialysis machines, dialysers, or peritoneal dialysis systems meet a verified safety and quality standard, supporting trust-based commercial relationships in a clinically sensitive specialty.
Nephrology devices imported without a valid CDSCO MD15 license face customs detention and potential seizure. For dialysis centres dependent on a continuous, reliable supply of haemodialysis consumables, dialysers, and cleaning cartridges, customs delays can directly disrupt patient treatment schedules. A valid MD15 license ensures imported nephrology equipment clears customs without disruption, supporting continuity of care for dialysis-dependent patients.
India's government has launched multiple initiatives to expand early detection and screening of kidney disease, alongside public dialysis programmes delivered through government and empanelled hospitals. CDSCO licensing is a mandatory eligibility requirement to supply devices into these programmes. Manufacturers and importers with a valid license gain access to a substantial and growing public health procurement channel that unlicensed competitors cannot reach.
With chronic kidney disease incidence in India directly tracking the rise in diabetes and hypertension, the underlying demand for nephrology devices is structurally durable, not cyclical. A CDSCO license with indefinite validity provides a long-term regulatory foundation from which manufacturers and importers can scale their nephrology device portfolio — adding new dialysis technologies, screening devices, and dialysis consumables — to meet this sustained growth trajectory.
CDSCO General Hospital Medical Device License India 2026 — Complete Guide
Nephrology device manufacturers whose portfolio also includes general hospital equipment — patient monitoring systems, infusion devices, or sterilization equipment used in dialysis units — should review the CDSCO licensing requirements for the general hospital device category, which apply alongside nephrology-specific licensing.
How Rego Services Supports Your CDSCO Application
Securing the CDSCO nephrology medical devices license is a substantial undertaking. It requires extensive knowledge of CDSCO's regulatory guidelines, careful classification of often highly specialised devices, and the preparation of multiple technically demanding supporting documents — making the application process arduous and time-consuming for companies navigating it without dedicated regulatory support. Rego Services Private Limited provides end-to-end support for CDSCO nephrology medical device license applications across all device classes and license types.
- Device classification confirmation and licensing strategy — We confirm the CDSCO class of your nephrology device, identify the applicable license type (MD5, MD9, or MD15), and assess whether an MD13 test license is required before the permanent license application.
- ISO 13485 certification support — Where ISO 13485 certification is not yet in place, we support the full certification process on a timeline coordinated with the CDSCO license application.
- Device Master File preparation — We prepare comprehensive Device Master Files for nephrology devices, with particular attention to the biocompatibility and haemocompatibility data that receives close CDSCO scrutiny for devices in direct blood contact.
- Plant Master File preparation — We prepare Plant Master Files that accurately describe the manufacturing facility in the level of detail CDSCO reviewers and inspectors expect, including GMP compliance evidence for Class C and D nephrology device manufacturing.
- Batch production and Certificate of Analysis support — We support the planning and documentation of the three consecutive batch production runs required for MD5 and MD9 applications.
- SUGAM portal submission management — We manage the complete online application process — form selection, document upload, fee payment, and formal submission — to avoid procedural delays.
- Query response and inspection preparation — We draft responses to CDSCO reviewer queries and prepare manufacturing facilities for CDSCO inspection, drawing on our experience of common query and inspection patterns for nephrology device applications.
- Post-grant compliance and retention fee management — We maintain retention fee compliance calendars and support ongoing CDSCO compliance after license grant, helping you avoid the automatic cancellation risk associated with missed retention fee deadlines.
Frequently Asked Questions
Are haemodialysis machines themselves classified, or only their components?
Both. Complete haemodialysis systems and many of their individual components are separately notified and classified under CDSCO's medical device schedule. For example, a haemodialysis system's central monitor, bicarbonate mixer, plasma filtration unit, and air/foam detector are each separately classified as Class C devices, while supporting accessories such as the haemodialysis crimp plier are Class A. Manufacturers producing complete haemodialysis systems with multiple component types should confirm the classification of each distinct component, since this affects which devices can be covered under a single license application and which fee structure applies.
Why do absorbable peritoneum catheter cuffs fall in Class D, the highest CDSCO risk category?
Absorbable peritoneum catheter cuffs — including collagen-containing variants — are classified as Class D because they are implantable devices that remain in direct, sustained contact with the peritoneal cavity and are designed to be absorbed by the body over time. This combination of implantable status, prolonged internal contact, and biological absorption carries a materially higher risk profile than externally connected dialysis equipment, which is why CDSCO subjects these devices to its most rigorous classification tier and corresponding MD9 manufacturing license requirements.
Does importing dialysis consumables (cleaning cartridges, test strips) require the same MD15 license as importing a complete haemodialysis machine?
Yes. Any notified nephrology medical device imported into India — whether a complete haemodialysis machine or a consumable component such as a citric acid cleaning cartridge or a dialysate water chlorine test strip — requires a valid MD15 import license from CDSCO. There is no quantity-based or consumable-specific exemption from this requirement. Importers supplying ongoing consumables to dialysis centres should ensure their MD15 license covers each distinct consumable product they intend to supply.
Can a manufacturer apply for MD5 and MD9 licenses simultaneously if their nephrology product range spans multiple classes?
Yes. Many nephrology device manufacturers produce a range spanning both lower-risk components (Class A or B, such as haemodialysis chairs) and higher-risk therapeutic devices (Class C or D, such as haemofilters). In this situation, separate MD5 and MD9 applications are required, since they are reviewed by different licensing authorities — the State Licensing Authority for MD5 and CDSCO Central for MD9. These applications can be prepared and filed concurrently to reduce overall elapsed time, even though each is assessed independently.
How does CDSCO's screening device initiative affect manufacturers entering the nephrology diagnostics space?
Government initiatives to expand early detection and screening of kidney disease are increasing demand for diagnostic and screening nephrology devices specifically, separate from the established demand for therapeutic devices like haemodialysis machines. Manufacturers entering this diagnostic and screening sub-segment should expect government and public health procurement channels to be a meaningful part of their go-to-market strategy, making CDSCO licensing — a mandatory eligibility condition for such procurement — a particularly important early priority.
✓ Key Takeaways
- Demand for nephrology medical devices in India is rising sharply, driven by increasing chronic kidney disease incidence linked to diabetes and hypertension, alongside historically low rates of early screening and diagnosis
- Nephrology devices span all four CDSCO risk classes — from haemodialysis chairs (Class A) and dialyser connectors (Class B) to haemofilters and automated peritoneal dialysis systems (Class C) and absorbable peritoneum catheter cuffs (Class D)
- Three license types apply: MD5 (manufacture Class A/B — State Licensing Authority, Rs. 5,000 + Rs. 500/device), MD9 (manufacture Class C/D — CDSCO Central, Rs. 50,000 + Rs. 1,000/device), and MD15 (import all classes — CDSCO Central)
- All three license types are valid indefinitely — but the retention fee must be paid every 5 years, or the license is automatically cancelled
- ISO 13485 certification and a comprehensive Device Master File — with particular emphasis on biocompatibility data for blood-contacting devices — are mandatory for all manufacturing license applications
- The CDSCO application process follows 5 structured steps: document preparation, SUGAM portal submission, query resolution, facility inspection (for manufacturing licenses), and license approval
- First-time manufacturers needing initial batch data will likely require an MD13 test license before applying for the permanent MD5 or MD9 license
Your Next Step
Nephrology medical devices occupy a uniquely demanding position in India's healthcare landscape — clinically essential to a growing population of kidney disease patients, while subject to some of CDSCO's most stringent classification and licensing requirements given the elevated patient risk many of these devices carry. For manufacturers and importers entering this segment, securing the correct CDSCO license is the foundation on which a compliant, commercially successful nephrology device business in India is built.
Rego Services' regulatory team brings deep familiarity with CDSCO's requirements across the full nephrology device spectrum — from Class A haemodialysis chairs through Class C haemofilters and dialysers to Class D absorbable catheter cuffs. With our support, the path from device classification through ISO 13485 certification, Device Master File and Plant Master File preparation, SUGAM portal submission, and license grant becomes a structured, manageable process rather than the arduous undertaking it can be without expert guidance.
Contact Rego Services today to discuss your CDSCO nephrology medical device license requirements and receive a device-specific regulatory plan with a realistic timeline for your India market entry.